chemotherapy Archives
Study seeks to ease ‘chemobrain’ for cancer patients
Aug. 20, 2015—Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment.
Drug combos enhance ovarian cancer cell death
Aug. 11, 2015—Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.
Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment
Jun. 25, 2015—Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.
Dietitian and friends donate chemo care bags to VICC patients
May. 28, 2015—A Nashville-based dietitian who lost her mother to cancer is using the power of social media to raise funds for chemo care bags for cancer patients.
Improving breast cancer chemo by testing tumors in a dish
Oct. 28, 2014—A team of biomedical engineers has developed a new "tumor-in-a-dish" technology that promises to improve the effectiveness of chemotherapy.
Potential mechanism for myeloma drug’s variable toxicity
Apr. 30, 2014—A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.
Overcoming resistance in ovarian cancer
Aug. 22, 2013—The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.
Predicting cancer’s response to therapy
Jun. 24, 2013—Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.
A drug combo for ovarian cancer
Dec. 24, 2012—Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer.
Vanderbilt identifies genes linked to breast cancer chemo resistance
Jun. 11, 2012—A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
Vanderbilt lands significant patient-centered research grant
May. 22, 2012—Patients and their families will have a more active role and voice in research designed to improve the quality and safety of patient care, thanks to a federal grant received by Vanderbilt University Medical Center researchers.
